Loading...

RNXT RENOVORX INC Management Changes 8-K Filing

RNVR

RNXT

RENOVORX INC

(RNXT)

2024 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Financial Results

Production Increase

Accountant Change

Departure of Directors and ...

Compliance with Nasdaq List...

Private Placement Offering

Private Placement Offering

Appointment of Chief Clinic...

Management Changes

Private Placement Offering

Passing of David Diamond

Submission of Matters to a ...

Earnings Reports

Listing Compliance Extension

Financial Results Announcement

Announcement of Positive In...

Annual Meeting of Stockholders

Financial Results Announcement

Appointment of Director

Securities Purchase Agreeme...

Financial Results and Clini...

External Links:

RenovoRx, Inc. appointed Leesa Gentry as Chief Clinical Officer, with an annual base salary of $325,000, an annual incentive bonus of up to 35% of her base salary, and an option to purchase 190,000 shares of the company's common stock.

AI Assistant

RENOVORX INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.